SELLAS Life Sciences (SLS) Intangibles (2014 - 2017)
SELLAS Life Sciences (SLS) reported Intangibles of $17.6 million for Q4 2017, up 90.17% year-over-year from $9.3 million in Q4 2016, and up 117.28% quarter-over-quarter from $8.1 million in Q3 2017.
SELLAS Life Sciences (SLS) Intangibles (2014 - 2017) Analysis & Trends
SELLAS Life Sciences (SLS) has 4 years of Intangibles data on file, last reported at $17.6 million in Q4 2017.
- Intangibles for Q4 2017 came in at $17.6 million, up 90.17% year-over-year; the trailing twelve-month figure through Dec 2017 was $17.6 million (up 90.17% YoY), and the FY2017 annual result was $17.6 million, up 90.17% from the prior year.
- Intangibles advanced to $17.6 million in Q4 2017 per SLS's latest filing, from $8.1 million in the prior quarter.
- Over five years, Intangibles peaked at $17.6 million in Q4 2017 and troughed at $2.1 million in Q1 2014.
- A 4-year average of $8.8 million and a median of $9.3 million in 2014 frame the typical range for Intangibles.
- The sharpest annual moves came in 2015 and 2017: Intangibles soared 338.63% in 2015, then retreated 12.48% in 2017.
- A 4-year view of Intangibles shows it stood at $9.3 million in 2014, then changed by 0.0% to $9.3 million in 2015, then changed by 0.0% to $9.3 million in 2016, then soared by 90.17% to $17.6 million in 2017.
- Business Quant data shows SLS's Intangibles at $17.6 million in Q4 2017, $8.1 million in Q3 2017, and $9.3 million in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 17.60 Mn |
| Sep 30, 2017 | 8.10 Mn |
| Jun 30, 2017 | 9.26 Mn |
| Mar 31, 2017 | 9.26 Mn |
| Dec 31, 2016 | 9.26 Mn |
| Sep 30, 2016 | 9.26 Mn |
| Jun 30, 2016 | 9.26 Mn |
| Mar 31, 2016 | 9.26 Mn |
| Dec 31, 2015 | 9.26 Mn |
| Sep 30, 2015 | 9.26 Mn |
| Jun 30, 2015 | 9.26 Mn |
| Mar 31, 2015 | 9.26 Mn |
| Dec 31, 2014 | 9.26 Mn |
| Sep 30, 2014 | 9.16 Mn |
| Jun 30, 2014 | 2.32 Mn |
| Mar 31, 2014 | 2.11 Mn |